These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3895878)

  • 21. Amrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Dec; 26(6):468-502. PubMed ID: 6360634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
    Alousi AA; Canter JM; Fort DJ
    Cardiovasc Res; 1985 Aug; 19(8):483-94. PubMed ID: 4042115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous amrinone.
    Goldstein RA; Naccarelli GV
    Ann Intern Med; 1985 Oct; 103(4):643-4. PubMed ID: 4037573
    [No Abstract]   [Full Text] [Related]  

  • 24. Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone.
    Guimond JG; Matuschak GM; Meyers F; Keating D
    Chest; 1986 Aug; 90(2):302-4. PubMed ID: 3731911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia and fever in a patient taking amrinone.
    Rubin SA; Lee S; O'Connor L; Hubenette A; Tober J; Swan HJ
    N Engl J Med; 1979 Nov; 301(21):1185. PubMed ID: 492292
    [No Abstract]   [Full Text] [Related]  

  • 26. Intravenous amrinone: an advance or a wrong step?
    Franciosa JA
    Ann Intern Med; 1985 Mar; 102(3):399-400. PubMed ID: 3970477
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic oral amrinone therapy in congestive heart failure: a double-blind placebo-controlled withdrawal study.
    Evans JR; Pacht K; Huss P; Unverferth DV; Bashore TM; Leier CV
    Int J Clin Pharmacol Res; 1984; 4(1):9-18. PubMed ID: 6381344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of low doses of amrinone to produce sustained hemodynamic improvement in patients with severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M
    Am J Cardiol; 1984 Nov; 54(8):1025-9. PubMed ID: 6496324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amrinone in acute and long-term therapy].
    Klepzig M; Kleinhans E; Büll U; Strauer BE
    Z Kardiol; 1985 Feb; 74(2):85-90. PubMed ID: 3922139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amrinone therapy in congestive cardiomyopathy.
    Reader C; Peyregne EA; Suárez LD
    Am Heart J; 1983 Jun; 105(6):1045. PubMed ID: 6858829
    [No Abstract]   [Full Text] [Related]  

  • 31. Amrinone in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS; Sutton MS; Wilson H; Rocci ML
    J Am Coll Cardiol; 1984 May; 3(5):1282-90. PubMed ID: 6707381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amrinone: acute electrophysiologic and hemodynamic effects in patients with congestive heart failure.
    Naccarelli GV; Gray EL; Dougherty AH; Hanna JE; Goldstein RA
    Am J Cardiol; 1984 Sep; 54(6):600-4. PubMed ID: 6475780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral and injectable amrinone in cardiac insufficiency].
    Massabuau P; Puel J; Miquel JP; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1984; 33(4):223-6. PubMed ID: 6465816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.
    LeJemtel TH; Keung E; Ribner HS; Davis R; Wexler J; Blaufox JD; Sonnenblick EH
    Am J Cardiol; 1980 Jan; 45(1):123-9. PubMed ID: 7350759
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term amrinone therapy in patients with severe heart failure: drug-dependent hemodynamic benefits despite progression of disease.
    Maskin CS; Forman R; Klein NA; Sonnenblick EH; LeJemtel TH
    Am J Med; 1982 Jan; 72(1):113-8. PubMed ID: 7058816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral amrinone in refractory congestive heart failure.
    Wynne J; Malacoff RF; Benotti JR; Curfman GD; Grossman W; Holman BL; Smith TW; Braunwald E
    Am J Cardiol; 1980 Jun; 45(6):1245-9. PubMed ID: 7377123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN
    Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 39. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 40. [Amrinone, a new cardiotonic agent].
    Taira N
    Nihon Rinsho; 1983 Dec; 41(12):2691-7. PubMed ID: 6371299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.